Home/Health And Wellness/

Pfizer begins Phase 2/3 study for COVID-19 oral antiviral in exposed adults

Jonny Smith Reply 07:04 A+ A-

Pfizer begins Phase 2/3 study for COVID-19 oral antiviral in exposed adults

Pfizer initiated a Phase 2/3 study of an investigational oral antiviral with a low dose of ritonavir to prevent COVID-19 illness, the company announced Monday.

Health And Wellness, Health Blogs, Health Care, Health Drinks, Health Drinks for Kids, Health is Wealth, Health Tips

Post a Comment

:noprob:

:smile:

:shy:

:trope:

:sneered:

:happy:

:escort:

:rapt:

:love:

:heart:

:angry:

:hate:

:sad:

:sigh:

:disappointed:

:cry:

:fear:

:surprise:

:unbelieve:

:shit:

:like:

:dislike:

:clap:

:cuff:

:fist:

:ok:

:file:

:link:

:place:

:contact:

Copyright (c) 2018 Healthell - Daily Viral Health News.